Cost-Effectiveness Analysis of Canacinumab In The Treatment of Patients Suffering From Systemic Juvenile Idiopathic Arthritis In Russian Federation
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2316
https://www.valueinhealthjournal.com/article/S1098-3015(15)04392-2/fulltext
Title :
Cost-Effectiveness Analysis of Canacinumab In The Treatment of Patients Suffering From Systemic Juvenile Idiopathic Arthritis In Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04392-2&doi=10.1016/j.jval.2015.09.2316
First page :
A646
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1727